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33 Transplant Centers Gain 
FAHCT Accreditation 
Thirty-three additional BMT centers have 
gained voluntary accreditation in the past 
six months. This brings to 63 the total 
number of centers accredited by the Foun- 
dation for Accreditation of Hematopoietic 
Cell Therapy (FAHCT). There are 125 other 
centers in various stages of application, 
inspection or accreditation pending. 
FAHCT accreditation is valid for three 
years. The first transplant programs to 
earn FAHCT accreditations nearly three 
years ago are now approaching their 
renewal dates for certification. 
The next course to assist facilities 
preparing for an on-site inspection will be 
held at the annual meeting of the Interna- 
tional Society of Hematotherapy and Graft 
Engineering (ISHAGE) on June 14 in Que- 
bec City, Canada. Centers interested in par- 
ticipating can contact the FAHCT Office for 
registration materials at (402) 595-1111 or 
www.fahct.org. 
FAHCT is also developing a new inspec- 
tor continuing education course, focusing 
on quality improvement. This workshop, 
too, will be offered at the ISHAGE meeting 
on June 14. 
The latest BMT facilities to gain volun- 
tary accreditation are listed in the cate- 
gories below: 
Autologous peripheral blood progenitor 
cell transplantation, including collection 
and laboratory processing: 
9 Baystate Medical Center, Springfield, Mass. 
9 Cancer Institute of New Jersey/Robert 
Wood Johnson University Hospital, New 
Brunswick, N.J. 
9 Holy Cross Hospital, Silver Spring, Md. 
9 Marshfield Cancer Center, Marshfield, Wis. 
9 Northwest Ohio Stem Cell Transplant 
Program, Toledo, Ohio 
9 Thompson Cancer Survival Center/Uni- 
versity of Tennessee Medical Center, 
Knoxville, Tenn. 
9 Walter Reed Army Medical Center, 
Washington, D.C. 
Autologous marrow and peripheral blood 
progenitor celt transplantation, including 
collection and laboratory processing: 
9 Halifax Medical Center, Daytona, Fla 
9 INOVA Fairfax Hospital Bone Marrow 
Transplant Program, Falls Church, Va 
9 SUNY Upstate Medical University, Syra- 
cuse, NY 
AIIogeneic marrow and autologous 
peripheral blood progenitor cell transplan- 
tation, including collection a d laboratory 
processing: 
9 University of Oklahoma Health Science 
Center, Oklahoma City, Okla 
AIIogeneic and autologous peripheral 
blood progenitor cell collection, marrow 
and peripheral blood progenitor cell trans- 
portation, processing and storage: 
9 The Canadian Blood Services, Ottawa, 
Ontario, Canada 
AIIogeneic and autologous marrow and 
autologous peripheral blood progenitor cell 
transplantation, including collection and 
laboratory processing: 
9 University of Wisconsin Hospital, Madi- 
son, Wis 
AIIogeneic and autologous marrow, periph- 
eral blood progenitor cell transplantation, 
including collection and laboratory processing. 
9 Blood and Marrow Transplant Group of 
Georgia, Atlanta, Ga. 
9 Children's Hospital and Dana-Farber 
Cancer Institute Pediatrics Hemato- 
poietic Stem Cell Transplantation Pro- 
gram, Boston, Mass. 
9 Dana-Farber Cancer Institute/Brigham 
and Women's Adult Hematopoietic Stem 
Cell Transplant Program, Boston, Mass. 
9 Fox Chase-Temple Bone Marrow Trans- 
plant Program, Philadelphia, Pa. 
9 Fred Hutchinson Cancer Research Cen- 
ter, Seattle, Wash. 
9 H. Lee Moffitt Cancer Center, Tampa, Fla. 
9 Massachusetts General Hospital, 
Boston, Mass. 
9 New England Medical Center, Boston, Mass. 
9 Northwest Marrow Transplant Program 
at Oregon - Health Sciences University 
Hospital, Legacy Good Samaritan Hospi- 
tal and Medical Center, and Doernbecher 
Children's Hospital, Portland, Ore 
9 Penn State Hershey Medical Center, Her- 
shey, Pa 
9 Tulane University Medical Center, New 
Orleans, La 
9 Umass Memorial Health Care Bone Mar- 
row Transplantation Program, Worces- 
ter, Mass 
9 University of Iowa Hospital and Clinics, 
Iowa City, Iowa 
9 University Medical Center, Tucson, Ariz 
9 University of Michigan Blood and Mar- 
row Stem Cell Transplantation Program, 
Ann Arbor, Mich 
9 University of Pittsburgh Cancer Institute, 
Pittsburgh, Pa 
9 University of Rochester Bone Marrow 
Transplantation Program, Rochester, NY
Attogeneic and autologous marrow, 
peripheral blood progenitor cell and cord 
blood ceil collection, processing and trans- 
plantation: 
9 UCLA Hematopoietic Stem Cell Trans- 
plant Program, Los Angeles, Calif 
AIIogeneic and autologous marrow and 
peripheral blood progenitor cell transplan- 
tation, including bone marrow collection, 
and also the PBPC collection and laborato- 
ry processing services provided by con- 
tract with the Canadian Blood Services: 
9 Ottawa General Hospital, Ottawa, 
Ontario, Canada 
Progenitor cell transportation, process- 
ing and storage of products for more than 
one clinical program: 
9 Progenitor Cell Therapy, Cellular Thera- 
py Laboratory, Hackensack, N J  
FAHCT Accreditation 
Summary 
9 63 Facilities accredited 
9 17 Inspections in progress 
9 63 Facilities inspected and awaiting 
accreditation 
9 45 Facilities registered in completing 
checklists 
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